Literature DB >> 32277928

A lncRNA Decoy Predicts Sensitivity to Cisplatin.

Raquel Boque-Sastre1, Sonia Guil2.   

Abstract

In a recent iScience paper by Fan et al., the long noncoding (lnc)RNA CISAL is shown to form a DNA-RNA triplex and to directly regulate BRCA1 transcription, thereby increasing cisplatin sensitivity and serving as a treatment efficacy biomarker. This opens promising avenues of research from both mechanistic and translational perspectives.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BRCA1; GABPA; TSCC; chemoresistance; lncRNA CISAL; triplex

Year:  2020        PMID: 32277928     DOI: 10.1016/j.molmed.2020.01.015

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  2 in total

1.  Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model.

Authors:  Dongdong Tang; Yangyang Li; Ying Tang; Haoxiang Zheng; Weihan Luo; Yuqing Li; Yingrui Li; Zhiping Wang; Song Wu
Journal:  Front Genet       Date:  2022-07-19       Impact factor: 4.772

Review 2.  LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer.

Authors:  Yue-Tao Tan; Jin-Fei Lin; Ting Li; Jia-Jun Li; Rui-Hua Xu; Huai-Qiang Ju
Journal:  Cancer Commun (Lond)       Date:  2020-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.